XCSE
RBREW
Market cap3.11bUSD
Sep 17, Last price
418.20DKK
1D
-0.67%
1Q
0.53%
Jan 2017
53.19%
Name
Royal Unibrew A/S
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Royal Unibrew A/S is a prominent beverage company engaged in the production, marketing, sale, and distribution of a broad spectrum of drinks. Its offerings encompass beer, malt beverages, various soft drinks, ciders, and ready-to-drink options. The company further diversifies its portfolio with carbonated beverages, bottled water, wines, spirits, juices, energy drinks, and cocktail products. These are sold under numerous proprietary brands, including Royal Beers, Lapin Kulta, Cido, Craft, Faxe Kondi, Ceres, Faxe, Original Long Drink, Lacplesis, Vitamalt, Mangali, Novelle, Nikoline, Kalnapilis, Egekidle, Supermalt, Polar Monkeys, Lorina, SHAKER, MOKAI, LemonSoda, Nohrlund, Power Malt, Fonti di Crodo, and CULT. Additionally, Royal Unibrew distributes international labels such as Heineken and products from PepsiCo. The company caters to clients across Denmark, Germany, Norway, Sweden, Italy, France, Finland, Lithuania, Latvia, Estonia, and other global markets. Founded in 1989, the enterprise was initially known as Bryggerigruppen A/S before rebranding to Royal Unibrew A/S in 2005. Its corporate headquarters are situated in Faxe, Denmark.
Related entities
Subsidiaries (3)
SIA "Cido Grupa"
Supermalt UK Limited
Uždaroji akcinė bendrovė "Kalnapilio-Tauro grupė"
Key people
Johannes F.C.M. Savonije
President, Chief Executive Officer, Member of the Executive Board · since 2017
Einar Esbensen Nielsen
Director, Employee Representative · since 2018
Claus Kaergaard
Director, Employee Representative · since 2018
Director · since 2019
Independent Director · since 2019
Headquarters & legal address
Faxe Alle 1
Faxe 4640
DK
Faxe 4640
DK
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||